Cardinal Health is a medical distribution business based in the US. Cardinal Health shares (CAH) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $121.84 – an increase of 2.58% over the previous week. Cardinal Health employs 47,922 staff and has a trailing 12-month revenue of around $224.5 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $121.84 |
|---|---|
| 52-week range | $92.74 - $126.14 |
| 50-day moving average | $113.50 |
| 200-day moving average | $106.46 |
| Wall St. target price | $123.82 |
| PE ratio | 23.7346 |
| Dividend yield | $2.012 (1.68%) |
| Earnings per share (TTM) | $5.20 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $123.42 from 2024-11-21
| 1 week (2024-11-15) | 3.91% |
|---|---|
| 1 month (2024-10-23) | 10.28% |
| 3 months (2024-08-21) | 12.56% |
| 6 months (2024-05-22) | 28.14% |
| 1 year (2023-11-22) | 16.57% |
|---|---|
| 2 years (2022-11-22) | 63.37% |
| 3 years (2021-11-22) | 176.30% |
| 5 years (2019-11-22) | 158.10% |
Valuing Cardinal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardinal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cardinal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Cardinal Health shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cardinal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0175. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardinal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cardinal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.9 billion.
The EBITDA is a measure of a Cardinal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $224.5 billion |
|---|---|
| Operating margin TTM | 1.05% |
| Gross profit TTM | $6.5 billion |
| Return on assets TTM | 3.18% |
| Return on equity TTM | 0% |
| Profit margin | 0.57% |
| Book value | $-13.54 |
| Market Capitalization | $29.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 26.43% of net profits
Recently Cardinal Health has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cardinal Health shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Cardinal Health's case, that would currently equate to about $2.012 per share.
While Cardinal Health's payout ratio might seem fairly standard, it's worth remembering that Cardinal Health may be investing much of the rest of its net profits in future growth.
Cardinal Health's most recent dividend payout was on 14 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 1 January 2025 (the "ex-dividend date").
Cardinal Health's shares were split on a 3:2 basis on 22 April 2001 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cardinal Health shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cardinal Health shares which in turn could have impacted Cardinal Health's share price.
Over the last 12 months, Cardinal Health's shares have ranged in value from as little as $92.7438 up to $126.135. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cardinal Health's is 0.616. This would suggest that Cardinal Health's shares are less volatile than average (for this exchange).
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.